Cleave Therapeutics

0 followers

‌

Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Amy Burroughs

President & CEO

Amy Burroughs

Collapse

Scott Harris

Chief Operating Officer

Jesse Vargas

Head of Research & Pre-Clinical Development

Teams

Board of Directors

9 members

Leadership Team

3 members

CEO and Executive Team

2 members

Similar companies

Dyno Therapeutics

4 followers

BioMarin Pharmaceutical

20 followers

Adaptive Biotechnologies

11 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Discover companies